Development of animal models for emerging infectious diseases by breaking the barrier of species susceptibility to human pathogens

References

• Munoz-Fontela C, Dowling WE, Funnell S, et al. Animal models for COVID-19. Nature. 2020;586(7830):509–515.
   PubMed Web of Science ®Google Scholar
• Bao L, Deng W, Huang B, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583(7818):830–833.
   PubMed Web of Science ®Google Scholar
• Yu P, Qi F, Xu Y, et al. Age-related rhesus macaque models of COVID-19. Animal Model Exp Med. 2020;3(1):93–97.
   PubMedGoogle Scholar
• Wei X, Rong N, Liu J. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2. Front Immunol. 2022;13:993754.
   PubMed Web of Science ®Google Scholar
• Bao L, Gao H, Deng W, et al. Transmission of severe acute respiratory syndrome coronavirus 2 via close contact and respiratory droplets among human angiotensin-converting enzyme 2 mice. J Infect Dis. 2020;222(4):551–555.
   PubMed Web of Science ®Google Scholar
• Deng W, Bao L, Gao H, et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nat Commun. 2020;11(1):4400.
   PubMed Web of Science ®Google Scholar
• Deng W, Bao L, Liu J, et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020;369(6505):818–823.
   PubMed Web of Science ®Google Scholar
• Chandrashekar A, Liu J, Martinot AJ, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;369(6505):812–817.
   PubMed Web of Science ®Google Scholar
• Cao Y, Su B, Guo X, et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell. 2020;182(1):73–84.e16.
   PubMed Web of Science ®Google Scholar
• Deng W, Xu Y, Kong Q, et al. Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo. Signal Transduct Target Ther. 2020;5(1):66.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay L, Yadav PD, Gupta N, et al. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J Med Res. 2021;153(1 & 2):93–114.
   PubMed Web of Science ®Google Scholar
• Nagata N, Iwata-Yoshikawa N, Taguchi F. Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models. Vet Pathol. 2010;47(5):881–892.
   PubMed Web of Science ®Google Scholar
• Rothenburg S, Brennan G. Species-specific host-virus interactions: implications for viral host range and virulence. Trends Microbiol. 2020;28(1):46–56.
   PubMed Web of Science ®Google Scholar
• Oliveira GP, Rodrigues RAL, Lima MT, et al. Poxvirus host range genes and virus-host spectrum: a critical review. Viruses. 2017;9(11):331.
   PubMed Web of Science ®Google Scholar
• Guo WN, Zhu B, Ai L, et al. Animal models for the study of hepatitis B virus infection. Zool Res. 2018;39(1):25–31.
   PubMed Web of Science ®Google Scholar
• Hessell AJ, Haigwood NL. Animal models in HIV-1 protection and therapy. Curr Opin Hiv Aids. 2015;10(3):170–176.
   PubMed Web of Science ®Google Scholar
• Sakata M, Tani H, Anraku M, et al. Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins. Sci Rep. 2017;7(1):11607.
   PubMedGoogle Scholar
• Pires DSG, Le Bideau M, Boschi C, et al. Choosing a cellular model to study SARS-CoV-2. Front Cell Infect Microbiol. 2022;12:1003608.
   PubMed Web of Science ®Google Scholar
• Jolly CL, Sattentau QJ. Attachment factors. Adv Exp Med Biol. 2013;790:1–23.
   PubMed Web of Science ®Google Scholar
• Schoggins JW. Interferon-stimulated genes: what do they all do? Annu Rev Virol. 2019;6(1):567–584.
   PubMed Web of Science ®Google Scholar
• Huthoff H, Towers GJ. Restriction of retroviral replication by APOBEC3G/F and TRIM5α. Trends Microbiol. 2008;16(12):612–619.
   PubMed Web of Science ®Google Scholar
• Martin-Sancho L, Lewinski MK, Pache L, et al. Functional landscape of SARS-CoV-2 cellular restriction. Mol Cell. 2021;81(12):2656–2668.e8.
   PubMed Web of Science ®Google Scholar
• Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008;451(7177):425–430.
   PubMed Web of Science ®Google Scholar
• Taylor JK, Coleman CM, Postel S, et al. Severe acute respiratory syndrome coronavirus ORF7a inhibits bone marrow stromal antigen 2 virion tethering through a novel mechanism of glycosylation interference. J Virol. 2015;89(23):11820–11833.
   PubMed Web of Science ®Google Scholar
• Wang SM, Huang KJ, Wang CT. BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface. Virology. 2014;449:287–296.
   PubMed Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251–254.
   PubMed Web of Science ®Google Scholar
• Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012;1:e49.
   PubMed Web of Science ®Google Scholar
• Yamayoshi S, Yamashita Y, Li J, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798–801.
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Shimojima M, Tano Y, et al. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794–797.
   PubMed Web of Science ®Google Scholar
• Wilen CB, Tilton JC, Doms RW. HIV: cell binding and entry. Cold Spring Harb Perspect Med. 2012;2(8):a006866–a006866.
   PubMed Web of Science ®Google Scholar
• Dalgleish AG, Beverley PC, Clapham PR, et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984;312(5996):763–767.
   PubMed Web of Science ®Google Scholar
• Agrawal AS, Garron T, Tao X, et al. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol. 2015;89(7):3659–3670.
   PubMed Web of Science ®Google Scholar
• van Doremalen N, Munster VJ. Animal models of Middle East respiratory syndrome coronavirus infection. Antiviral Res. 2015;122:28–38.
   PubMed Web of Science ®Google Scholar
• Imura A, Sudaka Y, Takashino A, et al. Development of an enterovirus 71 vaccine efficacy test using human scavenger receptor B2 transgenic mice. J Virol. 2020;94(6):e01921–19.
   PubMed Web of Science ®Google Scholar
• Li H, Zhuang Q, Wang Y, et al. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol Immunol. 2014;11(2):175–183.
   PubMed Web of Science ®Google Scholar
• Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215–220.
   PubMed Web of Science ®Google Scholar
• Yinda CK, Port JR, Bushmaker T, et al. K18-hACE2 mice develop respiratory disease resembling severe COVID-19. Plos Pathog. 2021;17(1):e1009195.
   PubMed Web of Science ®Google Scholar
• Kumari P, Rothan HA, Natekar JP, et al. Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice. Viruses. 2021;13(1):132.
   PubMed Web of Science ®Google Scholar
• Allen TM, Brehm MA, Bridges S, et al. Humanized immune system mouse models: progress, challenges and opportunities. Nat Immunol. 2019;20(7):770–774.
   PubMed Web of Science ®Google Scholar
• Theocharides AP, Rongvaux A, Fritsch K, et al. Humanized hemato-lymphoid system mice. Haematologica. 2016;101(1):5–19.
   PubMed Web of Science ®Google Scholar
• Abeynaike S, Paust S. Humanized mice for the evaluation of novel HIV-1 therapies. Front Immunol. 2021;12:636775.
   PubMed Web of Science ®Google Scholar
• Bility MT, Cheng L, Zhang Z, et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. Plos Pathog. 2014;10(3):e1004032.
   PubMed Web of Science ®Google Scholar
• Coronel-Ruiz C, Gutierrez-Barbosa H, Medina-Moreno S, et al. Humanized mice in dengue research: a comparison with other mouse models. Vaccines (Basel). 2020;8(1):39.
   PubMed Web of Science ®Google Scholar
• Dash PK, Gorantla S, Poluektova L, et al. Humanized mice for infectious and neurodegenerative disorders. Retrovirology. 2021;18(1):13.
   PubMed Web of Science ®Google Scholar
• Endsley JJ, Huante MB, Naqvi KF, et al. Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse. Retrovirology. 2021;18(1):14.
   PubMed Web of Science ®Google Scholar
• Terahara K, Iwabuchi R, Tsunetsugu-Yokota Y. Perspectives on non-BLT humanized mouse models for studying HIV pathogenesis and therapy. Viruses. 2021;13(5):776.
   PubMed Web of Science ®Google Scholar
• Allweiss L, Volz T, Lutgehetmann M, et al. Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. J Hepatol. 2014;60(3):500–507.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu N, Tesfaye A, et al. HCV infection-associated hepatocellular carcinoma in humanized mice. Infect Agent Cancer. 2015;10:24.
   PubMed Web of Science ®Google Scholar
• Heuts F, Gavier-Widen D, Carow B, et al. CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria. Proc Natl Acad Sci USA. 2013;110(16):6482–6487.
   PubMed Web of Science ®Google Scholar
• Lai F, Chen Q. Humanized mouse models for the study of infection and pathogenesis of human viruses. Viruses. 2018;10(11):643.
   PubMed Web of Science ®Google Scholar
• Skelton JK, Ortega-Prieto AM, Dorner M. A Hitchhiker’s guide to humanized mice: new pathways to studying viral infections. Immunology. 2018;154(1):50–61.
   PubMed Web of Science ®Google Scholar
• Legrand N, Ploss A, Balling R, et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe. 2009;6(1):5–9.
   PubMed Web of Science ®Google Scholar
• Guy RA, Belosevic M. Response of scid mice to establishment of Leishmania major infection. Clin Exp Immunol. 2008;100(3):440–445.
   Google Scholar
• Yoshimatsu K, Arikawa J, Ohbora S, et al. Hantavirus infection in SCID mice. J Vet Med Sci. 1997;59(10):863–868.
   PubMed Web of Science ®Google Scholar
• Butcher AR, Palethorpe HM, Grove DI. Effects of sex and age on the susceptibility of C57BL/6J mice to infection with Brachylaima cribbi and the course of infection in NOD SCID mice. Parasitol Res. 2002;88(7):668–674.
   PubMed Web of Science ®Google Scholar
• Muller U, Steinhoff U, Reis LF, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918–1921.
   PubMed Web of Science ®Google Scholar
• Rieger T, Merkler D, Gunther S. Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers. Plos One. 2013;8(8):e72290.
   PubMed Web of Science ®Google Scholar
• Aoki K, Shimada S, Simantini DS, et al. Type-I interferon response affects an inoculation dose-independent mortality in mice following Japanese encephalitis virus infection. Virol J. 2014;11:105.
   PubMed Web of Science ®Google Scholar
• Bray M. The role of the type I interferon response in the resistance of mice to filovirus infection. J Gen Virol. 2001;82(Pt 6):1365–1373.
   PubMed Web of Science ®Google Scholar
• Chessler AD, Caradonna KL, Da'Dara A, et al. Type I interferons increase host susceptibility to Trypanosoma cruzi infection. Infect Immun. 2011;79(5):2112–2119.
   PubMed Web of Science ®Google Scholar
• Chopy D, Detje CN, Lafage M, et al. The type I interferon response bridles rabies virus infection and reduces pathogenicity. J Neurovirol. 2011;17(4):353–367.
   PubMed Web of Science ®Google Scholar
• Dhondt KP, Mathieu C, Chalons M, et al. Type I interferon signaling protects mice from lethal henipavirus infection. J Infect Dis. 2013;207(1):142–151.
   PubMed Web of Science ®Google Scholar
• Najjar I, Fagard R. STAT1 and pathogens, not a friendly relationship. Biochimie. 2010;92(5):425–444.
   PubMed Web of Science ®Google Scholar
• Meraz MA, White JM, Sheehan KC, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996;84(3):431–442.
   PubMed Web of Science ®Google Scholar
• Jung SR, Ashhurst TM, West PK, et al. Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection. Plos Pathog. 2020;16(4):e1008525.
   PubMed Web of Science ®Google Scholar
• Leopold WC, Hole CR, Wozniak KL, et al. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol. 2014;193(8):4060–4071.
   PubMed Web of Science ®Google Scholar
• Sugawara I, Yamada H, Mizuno S. STAT1 knockout mice are highly susceptible to pulmonary mycobacterial infection. Tohoku J Exp Med. 2004;202(1):41–50.
   PubMed Web of Science ®Google Scholar
• Yun NE, Seregin AV, Walker DH, et al. Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol. 2013;87(19):10908–10911.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 2000;165(10):5392–5396.
   PubMed Web of Science ®Google Scholar
• Alexopoulou L, Thomas V, Schnare M, et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med. 2002;8(8):878–884.
   PubMed Web of Science ®Google Scholar
• Reiling N, Holscher C, Fehrenbach A, et al. Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol. 2002;169(7):3480–3484.
   PubMed Web of Science ®Google Scholar
• Kaiko GE, Loh Z, Spann K, et al. Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. J Allergy Clin Immunol. 2013;131(5):1331–1339.e10.
   PubMed Web of Science ®Google Scholar
• von Bernuth H, Picard C, Puel A, et al. Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans. Eur J Immunol. 2012;42(12):3126–3135.
   PubMed Web of Science ®Google Scholar
• Miao J, Chard LS, Wang Z, et al. Syrian hamster as an animal model for the study on infectious diseases. Front Immunol. 2019;10:2329.
   PubMed Web of Science ®Google Scholar
• Rosenke K, Meade-White K, Letko M, et al. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg Microbes Infect. 2020;9(1):2673–2684.
   PubMed Web of Science ®Google Scholar
• Sia SF, Yan LM, Chin A, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834–838.
   PubMed Web of Science ®Google Scholar
• Bao L, Song Z, Xue J, et al. Susceptibility and attenuated transmissibility of SARS-CoV-2 in domestic cats. J Infect Dis. 2021;223(8):1313–1321.
   PubMed Web of Science ®Google Scholar
• Iwatsuki-Horimoto K, Nakajima N, Ichiko Y, et al. Syrian hamster as an animal model for the study of human influenza virus infection. J Virol. 2018;92(4):e01693–17.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Parra G, Dobrovolny HM. Modeling of fusion inhibitor treatment of RSV in African green monkeys. J Theor Biol. 2018;456:62–73.
   PubMed Web of Science ®Google Scholar
• Hanley KA, Guerbois M, Kautz TF, et al. Infection dynamics of sylvatic dengue virus in a natural primate host, the African green monkey. Am J Trop Med Hyg. 2014;91(4):672–676.
   PubMed Web of Science ®Google Scholar
• Johnston SC, Briese T, Bell TM, et al. Detailed analysis of the African green monkey model of Nipah virus disease. Plos One. 2015;10(2):e0117817.
   PubMed Web of Science ®Google Scholar
• Garcia-Tellez T, Huot N, Ploquin MJ, et al. Non-human primates in HIV research: achievements, limits and alternatives. Infect Genet Evol. 2016;46:324–332.
   PubMed Web of Science ®Google Scholar
• Clancy CS, Shaia C, Munster V, et al. Histologic pulmonary lesions of SARS-CoV-2 in 4 nonhuman primate species: An institutional comparative review. Vet Pathol. 2022;59(4):673–680.
   PubMed Web of Science ®Google Scholar
• Nelson M, Salguero FJ, Hunter L, et al. A novel marmoset (Callithrix jacchus) model of human inhalational Q fever. Front Cell Infect Microbiol. 2021;10:621635.
   PubMed Web of Science ®Google Scholar
• Carrion RJ, Patterson JL. An animal model that reflects human disease: the common marmoset (Callithrix jacchus). Curr Opin Virol. 2012;2(3):357–362.
   PubMed Web of Science ®Google Scholar
• Iwatsuki-Horimoto K, Nakajima N, Kiso M, et al. The marmoset as an animal model of influenza: infection with A(H1N1)pdm09 and highly pathogenic A(H5N1) viruses via the conventional or tracheal spray route. Front Microbiol. 2018;9:844.
   PubMed Web of Science ®Google Scholar
• Mucker EM, Chapman J, Huzella LM, et al. Susceptibility of marmosets (Callithrix jacchus) to monkeypox virus: a low dose prospective model for monkeypox and smallpox disease. Plos One. 2015;10(7):e0131742.
   PubMed Web of Science ®Google Scholar
• Valdar W, Flint J, Mott R. Simulating the collaborative cross: power of quantitative trait loci detection and mapping resolution in large sets of recombinant inbred strains of mice. Genetics. 2006;172(3):1783–1797.
   PubMed Web of Science ®Google Scholar
• Abu TAH, Nashef A, Iraqi FA. The collaborative cross mouse model for dissecting genetic susceptibility to infectious diseases. Mamm Genome. 2018;29(7-8):471–487.
   PubMed Web of Science ®Google Scholar
• Durrant C, Tayem H, Yalcin B, et al. Collaborative cross mice and their power to map host susceptibility to Aspergillus fumigatus infection. Genome Res. 2011;21(8):1239–1248.
   PubMed Web of Science ®Google Scholar
• Lore NI, Iraqi FA, Bragonzi A. Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the collaborative cross mice. BMC Genet. 2015;16:106.
   PubMed Web of Science ®Google Scholar
• Vered K, Durrant C, Mott R, et al. Susceptibility to Klebsiella pneumonaie infection in collaborative cross mice is a complex trait controlled by at least three loci acting at different time points. Bmc Genomics. 2014;15:865.
   PubMed Web of Science ®Google Scholar
• Mcdonald B, Zucoloto AZ, Yu IL, et al. Programing of an intravascular immune firewall by the gut microbiota protects against pathogen dissemination during infection. Cell Host Microbe. 2020;28(5):660–668.e4.
   PubMed Web of Science ®Google Scholar
• Schnepf D, Hernandez P, Mahlakoiv T, et al. Rotavirus susceptibility of antibiotic-treated mice ascribed to diminished expression of interleukin-22. Plos One. 2021;16(8):e0247738.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Lee KA, Ma W, Sikavi DR, et al. Cancer and risk of COVID-19 through a general community survey. Oncologist. 2021;26(1):e182–5.
   PubMed Web of Science ®Google Scholar
• Ma Y, Lu D, Bao L, et al. SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice. Animal Model Exp Med. 2021;4(1):2–15.
   PubMedGoogle Scholar
• Han Y, Duan X, Yang L, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2021;589(7841):270–275.
   PubMed Web of Science ®Google Scholar
• Qian X, Nguyen HN, Song MM, et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell. 2016;165(5):1238–1254.
   PubMed Web of Science ®Google Scholar
• Han Y, Yang L, Lacko LA, et al. Human organoid models to study SARS-CoV-2 infection. Nat Methods. 2022;19(4):418–428.
   PubMed Web of Science ®Google Scholar